{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:34:46Z","timestamp":1770996886009,"version":"3.50.1"},"reference-count":55,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1586\/14737140.2.6.630","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T12:53:54Z","timestamp":1105620834000},"page":"630-640","source":"Crossref","is-referenced-by-count":24,"title":["Gemtuzumab ozogamicin: promise and challenge in patients with acute myeloid leukemia"],"prefix":"10.1586","volume":"2","author":[{"given":"Francis J","family":"Giles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1182\/blood.V98.13.3575","volume":"98","author":"Estey EH","year":"2001","journal-title":"Blood"},{"key":"CIT0004","first-page":"1312","volume":"98","author":"Grimwade D","year":"2001","journal-title":"B\/ood"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402622"},{"key":"CIT0007","first-page":"2969","volume":"90","author":"Estey E","year":"1997","journal-title":"On outcome of AML-type chemotherapy. Blood"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011015)92:8<1999::AID-CNCR1538>3.0.CO;2-B"},{"key":"CIT0009","first-page":"203","volume":"1","author":"Estey EH","year":"1987","journal-title":"Hematol Pathol"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood.V100.3.791","volume":"100","author":"Albitar M","year":"2002","journal-title":"Blood"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0145-2126(01)00170-9","volume":"26","author":"Lin CVV","year":"2002","journal-title":"Leuk. Res"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10200"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000046616","volume":"106","author":"Thomas DA","year":"2001","journal-title":"Acta liaematol"},{"key":"CIT0015","first-page":"372","volume":"96","author":"Albitar M","year":"2000","journal-title":"Differences between refractory anemia with excess blasts in transformation and acute myeloid leukemia. Blood"},{"key":"CIT0017","first-page":"1752","volume":"98","author":"Kottaridis PD","year":"2001","journal-title":"B\/ood"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/sj.onc.1205332","volume":"21","author":"Kiyoi H","year":"2002","journal-title":"Oncogene"},{"key":"CIT0020","first-page":"3074","volume":"93","author":"Kiyol H","year":"1999","journal-title":"Bkod"},{"key":"CIT0022","first-page":"268","volume":"86","author":"Raza A","year":"1995","journal-title":"Bkod"},{"key":"CIT0024","first-page":"881","volume":"115","author":"Zorat F","year":"2001","journal-title":"The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes. Br. liaematol"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401618"},{"key":"CIT0026","first-page":"61","volume":"26","author":"List AE Use of amifostine in hematologic malignancies, myelodysplastic syndrome and acute leukemia","year":"1999","journal-title":"Oncol"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/(SICI)1097-0320(19960301)23:3<250::AID-CYTO8>3.0.CO;2-M","volume":"23","author":"Qiao X","year":"1996","journal-title":"Cytometry"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"Bonnet D","year":"1997","journal-title":"Nature Med"},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1182\/blood.V97.10.3197","volume":"97","author":"van Der Velden VH","year":"2001","journal-title":"Blood"},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/1074-5521(94)90041-8","volume":"1","author":"Nicolaou KC","year":"1994","journal-title":"Chem. Biol"},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0968-0896(00)82187-2","volume":"2","author":"Hiatt A","year":"1994","journal-title":"Bioorg. Med. Chem"},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1073\/pnas.90.8.3142","volume":"90","author":"Nicolaou KC","year":"1993","journal-title":"Proc. Natl Acad. Li. USA"},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/sj.leu.2401851","volume":"14","author":"Naito K","year":"2000","journal-title":"Leukemia"},{"key":"CIT0038","first-page":"3336","volume":"53","author":"Hinman LM","year":"1993","journal-title":"Cancer Res"},{"key":"CIT0039","doi-asserted-by":"crossref","first-page":"10506","DOI":"10.1073\/pnas.92.23.10506","volume":"92","author":"Ikemoto N","year":"1995","journal-title":"Pmc. Natl Acad. Li. USA"},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/tx00027a001","volume":"5","author":"Dedon PC","year":"1992","journal-title":"Chem. Res. Toxicol"},{"key":"CIT0044","first-page":"1490","volume":"7","author":"Bross PF","year":"2001","journal-title":"Clin. Cancer Res"},{"key":"CIT0045","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/sj.leu.2402677","volume":"16","author":"Larson RA","year":"2002","journal-title":"Leukemia"},{"key":"CIT0048","first-page":"7","volume":"92","author":"Cortes J","year":"2001","journal-title":"High- dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia. Cancer"},{"key":"CIT0051","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00280-002-0539-y","volume":"50","author":"Cortes J","year":"2002","journal-title":"Cancer Chemo. Pharmacol"},{"key":"CIT0053","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood.V98.4.988","volume":"98","author":"Linenberger ML","year":"2001","journal-title":"Blood"},{"key":"CIT0054","first-page":"3212","volume":"98","author":"List AF","year":"2001","journal-title":"B\/ood"},{"key":"CIT0055","first-page":"81","volume":"17","author":"Cortes J","year":"1999","journal-title":"Phase I study of liposomal daunorubicin in patients with acute leukemia. Invest. New Drugs"},{"key":"CIT0058","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1200\/JCO.2001.19.3.762","volume":"19","author":"Giles FJ","year":"2001","journal-title":"J. Clin. aka"},{"key":"CIT0060","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11912-002-0029-8","volume":"4","author":"Giles FJ","year":"2002","journal-title":"ONT. Oncol Rep"},{"key":"CIT0061","first-page":"4343","volume":"99","author":"Estey EH","year":"2002","journal-title":"B\/ood"},{"key":"CIT0065","first-page":"139","volume":"72","author":"Beran M","year":"2000","journal-title":"Lit. j Hematol"},{"key":"CIT0066","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1200\/JCO.1994.12.4.671","volume":"12","author":"Estey E","year":"1994","journal-title":"Clin. Oncol"},{"key":"CIT0067","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1182\/blood.V93.8.2478","volume":"93","author":"Estey EH","year":"1999","journal-title":"Blood"},{"key":"CIT0071","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1182\/blood.V94.7.2230.419k05_2230_2235","volume":"94","author":"Estey EH","year":"1999","journal-title":"Blood"},{"key":"CIT0073","first-page":"4222","volume":"99","author":"Estey EH","year":"2002","journal-title":"B\/ood"},{"key":"CIT0075","first-page":"2310","volume":"99","author":"Rajvanshi P","year":"2002","journal-title":"B\/ood"},{"key":"CIT0076","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/sj.bmt.1703242","volume":"28","author":"Tack DK","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"CIT0077","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/sj.bmt.1703602","volume":"30","author":"Cohen AD","year":"2002","journal-title":"Bone Marrow Tiansplant"},{"key":"CIT0081","first-page":"587a","volume":"98","author":"Lim J","year":"2001","journal-title":"B\/ood"},{"key":"CIT0083","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/1097-0142(20010715)92:2<406::AID-CNCR1336>3.0.CO;2-U","volume":"92","author":"Giles FJ","year":"2001","journal-title":"Cancer"},{"key":"CIT0085","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1177\/00912700122012751","volume":"41","author":"Dowell JA","year":"2001","journal-title":"J. Clin. Pharmacol"},{"key":"CIT0086","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1126\/science.3240341","volume":"240","author":"Zein N","year":"1988","journal-title":"Science"},{"key":"CIT0091","first-page":"212b","volume":"98","author":"Giles F","year":"2001","journal-title":"Phase II study of Mylotarg plus troxatyl in patients with refractory acute myeloid leukemia or myelodysplastic syndrome. Dood"},{"key":"CIT0093","first-page":"1114","volume":"87","author":"Giles F","year":"2002","journal-title":"I-Lematologica"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198712000-00011"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198506000-00005"},{"key":"CIT0099","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1046\/j.1365-2141.2000.02475.x","volume":"111","author":"Chopra R","year":"2000","journal-title":"Br J. I-Lematol"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14737140.2.6.630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T09:09:39Z","timestamp":1586077779000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14737140.2.6.630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2002,12]]}},"alternative-id":["10.1586\/14737140.2.6.630"],"URL":"https:\/\/doi.org\/10.1586\/14737140.2.6.630","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}